Insulin resistance and neurodegeneration: Roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis

被引：0
|
作者：
de la Monte, Suzanne M. [1 ,2 ,3 ]
Longato, Lisa [1 ]
Tong, Ming [1 ,4 ,5 ]
Wands, Jack R. [1 ,4 ,5 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Rhode Isl Hosp, Div Neuropathol, Dept Pathol, Providence, RI 02903 USA
[3] Rhode Isl Hosp, Dept Neurol, Providence, RI 02903 USA
[4] Rhode Isl Hosp, Dept Med, Div Gastroenterol, Providence, RI 02903 USA
[5] Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA
来源：
CURRENT OPINION IN INVESTIGATIONAL DRUGS | 2009年 / 10卷 / 10期
关键词：
BBB; blood-brain barrier; ceramide; dementia; insulin resistance; liver-brain axis; obesity; type 2 diabetes mellitus; FATTY LIVER-DISEASE; GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; CHRONIC HEPATITIS-C; ALZHEIMERS-DISEASE; INTRANASAL INSULIN; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; FACTOR EXPRESSION;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Recent studies have linked obesity, type 2 diabetes mellitus (T2DM) or non-alcoholic steatohepatitis (NASH) to insulin resistance in the brain, cognitive impairment and neurodegeneration. Insulin resistance compromises cell survival, metabolism and neuronal plasticity, and increases oxidative stress, cytokine activation and apoptosis. T2DM/NASH has been demonstrated to be associated with increased ceramide generation, suggesting a mechanistic link between peripheral insulin resistance and neurodegeneration because ceramides mediate insulin resistance and can cross the blood-brain barrier (BBB). Peripheral insulin resistance diseases may potentially cause brain insulin resistance via a liver-brain axis of neurodegeneration as a result of the trafficking of ceramides across the BBB. Therapy that includes insulin-sensitizing agents may help prevent brain insulin resistance-mediated cognitive impairment.
引用
收藏
页码：1049 / 1060
页数：12
相关论文
共 50 条
  • [1] Non-alcoholic steatohepatitis in type 2 diabetes mellitus
    Gupte, P
    Amarapurkar, D
    Agal, S
    Baijal, R
    Kulshrestha, P
    Pramanik, S
    Patel, N
    Madan, A
    Amarapurkar, A
    Hafeezunnisa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (08) : 854 - 858
  • [2] Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis
    Lyn-Cook, Lascelles E.
    Lawton, Margot
    Tong, Ming
    Silbermann, Elizabeth
    Longato, Lisa
    Jiao, Ping
    Mark, Princess
    Wands, Jack R.
    Xu, Haiyan
    de la Monte, Suzanne M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) : 715 - 729
  • [3] The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Shinde, Shraddha
    Nelson, David R.
    Mitroi, Jessica
    Heaton, Pamela C.
    Hincapie, Ana L.
    Brouwers, Bram
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (01) : 59 - 68
  • [4] Insulin resistance in non-alcoholic steatohepatitis
    Cömert, B
    Mas, MR
    Erdem, H
    Dinc, A
    Saglamkaya, U
    Cigerim, M
    Kuzhan, O
    Unal, T
    Kocabalkan, F
    [J]. DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) : 353 - 358
  • [5] Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
    Lauren Parlett
    Qinli Ma
    Qian Shi
    Geoffrey Crawford
    Laura Herrera Scott
    Vincent Willey
    Abiy Agiro
    [J]. Diabetology & Metabolic Syndrome, 13
  • [6] Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
    Parlett, Lauren
    Ma, Qinli
    Shi, Qian
    Crawford, Geoffrey
    Herrera Scott, Laura
    Willey, Vincent
    Agiro, Abiy
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [7] Type 2 diabetes mellitus complicated with smoldering myeloma and non-alcoholic steatohepatitis
    Nakahara, T
    Utsugi, T
    Ohyama, Y
    Tomono, S
    Sato, K
    Takagi, H
    Murakami, H
    Hasegawa, A
    Kurabayashi, M
    [J]. INTERNAL MEDICINE, 2005, 44 (08) : 838 - 842
  • [8] A Current Approach to Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients
    Stan, Sorina I.
    Biciusca, Teodora
    Biciusca, Viorel
    Cioboata, Ramona
    Clenciu, Diana
    Mitrea, Adina
    Ghenea, Alice Elena
    Danoiu, Suzana
    [J]. GASTROENTEROLOGY INSIGHTS, 2023, 14 (03) : 363 - 382
  • [9] Non-alcoholic steatohepatitis (NASH) in children and adolescents with type 2 diabetes mellitus
    Newfield, R
    Schwimmer, J
    [J]. DIABETES, 2003, 52 : A404 - A404
  • [10] Nitrosamine Exposure Causes Insulin Resistance Diseases: Relevance to Type 2 Diabetes Mellitus, Non-Alcoholic Steatohepatitis, and Alzheimer's Disease
    Tong, Ming
    Neusner, Alexander
    Longato, Lisa
    Lawton, Margot
    Wands, Jack R.
    de la Monte, Suzanne M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (04) : 827 - 844
12345